Softgel Capsules Market By Type (Gelatin Softgel Capsules, Non-Gelatin softgel Capsules), By Application (Pharmaceuticals, Health Supplements, Cosmetics), By Distribution Channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2031

Softgel Capsules Market

Softgel capsules are solid, single-dose dosage forms consisting of a shell, usually made from gelatin, that generally contain liquids. Gelatin is the most widely used film-forming agent, and it is extracted from collagen through hydrolysis. However, it is also possible to use starch and cellulose derivatives, such as hydroxypropyl methylcellulose, to form the thin ribbons required for the production of softgel capsules.

Softgel capsules market trends that drive the growth of the market include, increase in demand for softgel capsules in developed countries such as U.S, rapid development of the e-commerce industry due to easy access to e-commerce, and wide availability of smart device. In addition, increase in government expenditure on healthcare further fuels the growth of the market.

Conversely, high manufacturing cost of vegetarian softgel capsules, owing to their specialized raw material and production processes are expected to limit the growth of the market during the forecast period. On the other hand, surge in innovations in the pharmaceutical industry for the production of softgel capsule owing to massive pool of health-conscious consumers is expected to offer profitable opportunities for the softgel capsules market growth during the forecast period.

COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The COVID-19 pandemic has helped the softgel capsules industry grow significantly, as demand for softgel health supplements to improve immune system during COVID-19. Popular supplement ingredients that are thought to support immune health include, vitamin C, vitamin D, zinc, elderberry, echinacea, and probiotics, which are also available in softgels.

Depending on type, the market is bifurcated into gelatin softgel capsules and non-gelatin softgel capsules. The gelatin softgel capsules exhibited highest growth in 2021, owing to increase in usage of gelatin to produce capsules, due to its physicochemical, biological, and mechanical properties. Moreover, gelatin-based capsules are cost effective, thereby resulting in more adoption, which further drives the growth of the segment.

On the other hand, the non-gelatin softgel capsules segment is expected to register highest CAGR during the forecast period. This is attributed to increase in vegan population, which increases the demand for vegetarian softgel capsules.

On the basis of application, the market is segmented into pharmaceuticals, health supplements, and cosmetics. The health supplements segment exhibited the highest growth in 2021, and is anticipated to continue this trend during the forecast period. This is attributed to high adoption of health supplements, surge in awareness toward preventative healthcare, and increase in usage of omega-3 supplements in emerging economies.

On the other hand, the pharmaceutical segment expected to register highest CAGR during forecast period. This is attributed to the advantages of softgel capsules in pharmaceutical applications as they aid in the improvement of active medicinal component bioavailability (APIs).

On the basis of distribution channel, the market is classified into supermarket & hypermarket, pharmacies & drug stores, and online providers. At present, the pharmacies & drug stores segment is the major revenue contributor, and is projected to remain dominant during the forecast period. This is attributed to the higher presence of pharmacies & drug stores and ease of availability of softgel capsules in pharmacies & drug stores. Moreover, they are certified to keep several types of drug stock, which promote the growth of the segment.

However, the online provider segment is expected to exhibit rapid growth in the near future, due to rise in number of netizens and increase in awareness about online pharmacy. In addition, lockdowns at the regional and national levels have disrupted the offline supply chain. As a result, competitors are concentrating on e-commerce networks, collaborating with governments to supply, and raising awareness of e-commerce pharmacies, which further fuel growth of the segment.

Region-wise, North America had the highest softgel capsules market share in 2021, and is expected to maintain its lead during the forecast period. This is attributed to higher demand for softgel capsules, rise in number of self-directed consumers, and supportive reimbursement policies in the healthcare system.

However, Asia-Pacific is expected to witness the highest growth rate during the forecast period, majorly due to rise in adoption of health softgel, surge in healthcare awareness, and increase in number of R&D activities to develop novel therapeutics.  

Key findings of the study

• By type, the gelatin softgel capsules segment was highest contributor to the market in 2021.

• By application, the health supplements segment dominated the market in 2021, and is expected to continue this trend during the forecast period.

• By distribution channel, the pharmacies & drug stores dominated the market in 2021, and is expected to grow at a CAGR of 5.0%

• Region-wise, North America generated the largest revenue share in 2021, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Overview

The global softgel capsules market was valued at $4,424.23 million in 2021, and is projected to reach $7,499.07 million by 2031, registering a CAGR of 5.4% from 2022 to 2031. 

A softgel or soft gelatin capsule is a solid capsule (outer shell) surrounding a liquid or semi-solid center (inner fill). An active ingredient can be incorporated into the outer shell, the inner fill, or both. They are oral dosage form for medicine similar to capsules. There are two types of softgel capsules, namely gelatin softgel capsule and vegetarian softgel capsules. Gelatin sоftgеl іѕ uѕuаllу а ѕіnglе ріесе оf сарѕulе, соmmоnlу mаdе оf gеlаtіn аnd соnѕіѕtѕ оf lіquіd оr оіl-bаѕеd іngrеdіеntѕ. On the other hand, vegetarian softgel capsules are oral dosage of medicines and nutritional supplements delivered in the form of capsules. They are made from starch, pullulan, and cellulose (Hydroxypropyl Methylcellulose).

The growth of global softgel capsules market is majorly driven by increase in demand for softgel capsules owing to rise in number of health-conscious people as well as growth in innovations in the pharmaceutical industry. In addition, rapid development of of e-commerce industry and increase in government expenditure on healthcare are factors responsible for the market growth. 

However, poor demand for softgel capsule in underdeveloped countries and high cost of vegetarian softgel capsules are some restraints that hinders the market growth. On the other hand, high growth potential in emerging markets and growth in vegan population are expected to offer profitable opportunities for the growth of the market during the forecast period.

The softgel capsules market is segmented into type, application, distribution channel, and region. By type, the market is categorized into gelatin softgel capsules and non-gelatin softgel capsules. On the basis of application, the market is segregated into pharmaceuticals, health supplements, and cosmetics. By distribution channel, the market is classified into supermarkets & hypermarkets, pharmacies & drug stores, and online providers. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global softgel capsules market are Aenova Group, Best Formulations, Inc., Captek Softgel International, Inc., Catalant, Inc., DCC Plc. (Eurocaps), Procaps Groups, Robinson Pharma, Inc., Lyfe Group (Caps Canada), Sirio Pharma Co. (Ayanda), and Thermofisher Scientific, Inc. (Patheon). 

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the softgel capsule market analysis from 2021 to 2031 to identify the prevailing softgel capsule market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the softgel capsule market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global softgel capsule market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Thermofisher Scientific, Inc (Patheon

Scope of Softgel Capsules Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

3.7.Patent Landscape

4.1 Overview

4.1.1 Market size and forecast

4.2 Gelatin Softgel Capsules

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market share analysis by country

4.3 Non-Gelatin softgel Capsules

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market share analysis by country

4.3.4 Non-Gelatin softgel Capsules Softgel Capsules Market by Material

4.3.4.1 Starch Market size and forecast, by region

4.3.4.2 Cellulose Market size and forecast, by region

4.3.4.3 Pullulan Market size and forecast, by region

5.1 Overview

5.1.1 Market size and forecast

5.2 Pharmaceuticals

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market share analysis by country

5.3 Health Supplements

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market share analysis by country

5.4 Cosmetics

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market share analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Supermarkets and Hypermarkets

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market share analysis by country

6.3 Pharmacies and Drug Stores

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market share analysis by country

6.4 Online Providers

6.4.1 Key market trends, growth factors and opportunities

6.4.2 Market size and forecast, by region

6.4.3 Market share analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by Type

7.2.2.1 North America Non-Gelatin softgel Capsules Softgel Capsules Market by Material

7.2.3 North America Market size and forecast, by Application

7.2.4 North America Market size and forecast, by Distribution Channel

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Key market trends, growth factors and opportunities

7.2.5.1.2 Market size and forecast, by Type

7.2.5.1.3 Market size and forecast, by Application

7.2.5.1.4 Market size and forecast, by Distribution Channel

7.2.5.2 Canada

7.2.5.2.1 Key market trends, growth factors and opportunities

7.2.5.2.2 Market size and forecast, by Type

7.2.5.2.3 Market size and forecast, by Application

7.2.5.2.4 Market size and forecast, by Distribution Channel

7.2.5.3 Mexico

7.2.5.3.1 Key market trends, growth factors and opportunities

7.2.5.3.2 Market size and forecast, by Type

7.2.5.3.3 Market size and forecast, by Application

7.2.5.3.4 Market size and forecast, by Distribution Channel

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by Type

7.3.2.1 Europe Non-Gelatin softgel Capsules Softgel Capsules Market by Material

7.3.3 Europe Market size and forecast, by Application

7.3.4 Europe Market size and forecast, by Distribution Channel

7.3.5 Europe Market size and forecast, by country

7.3.5.1 Germany

7.3.5.1.1 Key market trends, growth factors and opportunities

7.3.5.1.2 Market size and forecast, by Type

7.3.5.1.3 Market size and forecast, by Application

7.3.5.1.4 Market size and forecast, by Distribution Channel

7.3.5.2 France

7.3.5.2.1 Key market trends, growth factors and opportunities

7.3.5.2.2 Market size and forecast, by Type

7.3.5.2.3 Market size and forecast, by Application

7.3.5.2.4 Market size and forecast, by Distribution Channel

7.3.5.3 UK

7.3.5.3.1 Key market trends, growth factors and opportunities

7.3.5.3.2 Market size and forecast, by Type

7.3.5.3.3 Market size and forecast, by Application

7.3.5.3.4 Market size and forecast, by Distribution Channel

7.3.5.4 Italy

7.3.5.4.1 Key market trends, growth factors and opportunities

7.3.5.4.2 Market size and forecast, by Type

7.3.5.4.3 Market size and forecast, by Application

7.3.5.4.4 Market size and forecast, by Distribution Channel

7.3.5.5 Spain

7.3.5.5.1 Key market trends, growth factors and opportunities

7.3.5.5.2 Market size and forecast, by Type

7.3.5.5.3 Market size and forecast, by Application

7.3.5.5.4 Market size and forecast, by Distribution Channel

7.3.5.6 Rest of Europe

7.3.5.6.1 Key market trends, growth factors and opportunities

7.3.5.6.2 Market size and forecast, by Type

7.3.5.6.3 Market size and forecast, by Application

7.3.5.6.4 Market size and forecast, by Distribution Channel

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by Type

7.4.2.1 Asia-Pacific Non-Gelatin softgel Capsules Softgel Capsules Market by Material

7.4.3 Asia-Pacific Market size and forecast, by Application

7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 Japan

7.4.5.1.1 Key market trends, growth factors and opportunities

7.4.5.1.2 Market size and forecast, by Type

7.4.5.1.3 Market size and forecast, by Application

7.4.5.1.4 Market size and forecast, by Distribution Channel

7.4.5.2 China

7.4.5.2.1 Key market trends, growth factors and opportunities

7.4.5.2.2 Market size and forecast, by Type

7.4.5.2.3 Market size and forecast, by Application

7.4.5.2.4 Market size and forecast, by Distribution Channel

7.4.5.3 India

7.4.5.3.1 Key market trends, growth factors and opportunities

7.4.5.3.2 Market size and forecast, by Type

7.4.5.3.3 Market size and forecast, by Application

7.4.5.3.4 Market size and forecast, by Distribution Channel

7.4.5.4 Australia

7.4.5.4.1 Key market trends, growth factors and opportunities

7.4.5.4.2 Market size and forecast, by Type

7.4.5.4.3 Market size and forecast, by Application

7.4.5.4.4 Market size and forecast, by Distribution Channel

7.4.5.5 South Korea

7.4.5.5.1 Key market trends, growth factors and opportunities

7.4.5.5.2 Market size and forecast, by Type

7.4.5.5.3 Market size and forecast, by Application

7.4.5.5.4 Market size and forecast, by Distribution Channel

7.4.5.6 Rest of Asia-Pacific

7.4.5.6.1 Key market trends, growth factors and opportunities

7.4.5.6.2 Market size and forecast, by Type

7.4.5.6.3 Market size and forecast, by Application

7.4.5.6.4 Market size and forecast, by Distribution Channel

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by Type

7.5.2.1 LAMEA Non-Gelatin softgel Capsules Softgel Capsules Market by Material

7.5.3 LAMEA Market size and forecast, by Application

7.5.4 LAMEA Market size and forecast, by Distribution Channel

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Brazil

7.5.5.1.1 Key market trends, growth factors and opportunities

7.5.5.1.2 Market size and forecast, by Type

7.5.5.1.3 Market size and forecast, by Application

7.5.5.1.4 Market size and forecast, by Distribution Channel

7.5.5.2 Saudi Arabia

7.5.5.2.1 Key market trends, growth factors and opportunities

7.5.5.2.2 Market size and forecast, by Type

7.5.5.2.3 Market size and forecast, by Application

7.5.5.2.4 Market size and forecast, by Distribution Channel

7.5.5.3 South Africa

7.5.5.3.1 Key market trends, growth factors and opportunities

7.5.5.3.2 Market size and forecast, by Type

7.5.5.3.3 Market size and forecast, by Application

7.5.5.3.4 Market size and forecast, by Distribution Channel

7.5.5.4 Rest of LAMEA

7.5.5.4.1 Key market trends, growth factors and opportunities

7.5.5.4.2 Market size and forecast, by Type

7.5.5.4.3 Market size and forecast, by Application

7.5.5.4.4 Market size and forecast, by Distribution Channel

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 Aenova Group

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 Best Formulations, Inc.

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 Captek Softgel International, Inc.

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4 Catalant, Inc.

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 DCC Plc. (Eurocaps)

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 Procaps Groups

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 Robinson Pharma, Inc.

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 Lyfe Group (Caps Canada)

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 Sirio Pharma Co. (Ayanda)

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 Thermofisher Scientific, Inc (Patheon)

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 2. SOFTGEL CAPSULES MARKET, FOR GELATIN SOFTGEL CAPSULES, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 3. SOFTGEL CAPSULES MARKET, FOR GELATIN SOFTGEL CAPSULES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 4. SOFTGEL CAPSULES MARKET, FOR NON-GELATIN SOFTGEL CAPSULES, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 5. SOFTGEL CAPSULES MARKET, FOR NON-GELATIN SOFTGEL CAPSULES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 6. GLOBAL NON-GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULES MARKET, BY MATERIAL, 2021-2031 (REVENUE, $MILLION)

TABLE 7. SOFTGEL CAPSULES MARKET, FOR STARCH, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 8. SOFTGEL CAPSULES MARKET, FOR CELLULOSE, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 9. SOFTGEL CAPSULES MARKET, FOR PULLULAN, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 10. GLOBAL SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 11. SOFTGEL CAPSULES MARKET, FOR PHARMACEUTICALS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 12. SOFTGEL CAPSULES MARKET, FOR PHARMACEUTICALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 13. SOFTGEL CAPSULES MARKET, FOR HEALTH SUPPLEMENTS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 14. SOFTGEL CAPSULES MARKET, FOR HEALTH SUPPLEMENTS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 15. SOFTGEL CAPSULES MARKET, FOR COSMETICS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 16. SOFTGEL CAPSULES MARKET, FOR COSMETICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 17. GLOBAL SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 18. SOFTGEL CAPSULES MARKET, FOR SUPERMARKETS AND HYPERMARKETS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 19. SOFTGEL CAPSULES MARKET, FOR SUPERMARKETS AND HYPERMARKETS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 20. SOFTGEL CAPSULES MARKET, FOR PHARMACIES AND DRUG STORES, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 21. SOFTGEL CAPSULES MARKET, FOR PHARMACIES AND DRUG STORES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 22. SOFTGEL CAPSULES MARKET, FOR ONLINE PROVIDERS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 23. SOFTGEL CAPSULES MARKET, FOR ONLINE PROVIDERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 24. SOFTGEL CAPSULES MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 25. NORTH AMERICA SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 26. NORTH AMERICA NON-GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULES MARKET, BY MATERIAL, 2021-2031 (REVENUE, $MILLION)

TABLE 27. NORTH AMERICA SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 28. NORTH AMERICA SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 29. NORTH AMERICA SOFTGEL CAPSULES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 30. U.S. SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 31. U.S. SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 32. U.S. SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 33. CANADA SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 34. CANADA SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 35. CANADA SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 36. MEXICO SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 37. MEXICO SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 38. MEXICO SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 39. EUROPE SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 40. EUROPE NON-GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULES MARKET, BY MATERIAL, 2021-2031 (REVENUE, $MILLION)

TABLE 41. EUROPE SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 42. EUROPE SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 43. EUROPE SOFTGEL CAPSULES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 44. GERMANY SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 45. GERMANY SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 46. GERMANY SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 47. FRANCE SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 48. FRANCE SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 49. FRANCE SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 50. UK SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 51. UK SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 52. UK SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 53. ITALY SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 54. ITALY SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 55. ITALY SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 56. SPAIN SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 57. SPAIN SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 58. SPAIN SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 59. REST OF EUROPE SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 60. REST OF EUROPE SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 61. REST OF EUROPE SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 62. ASIA-PACIFIC SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 63. ASIA-PACIFIC NON-GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULES MARKET, BY MATERIAL, 2021-2031 (REVENUE, $MILLION)

TABLE 64. ASIA-PACIFIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 65. ASIA-PACIFIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 66. ASIA-PACIFIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 67. JAPAN SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 68. JAPAN SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 69. JAPAN SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 70. CHINA SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 71. CHINA SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 72. CHINA SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 73. INDIA SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 74. INDIA SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 75. INDIA SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 76. AUSTRALIA SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 77. AUSTRALIA SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 78. AUSTRALIA SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 79. SOUTH KOREA SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 80. SOUTH KOREA SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 81. SOUTH KOREA SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 82. REST OF ASIA-PACIFIC SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 83. REST OF ASIA-PACIFIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 84. REST OF ASIA-PACIFIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 85. LAMEA SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 86. LAMEA NON-GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULES MARKET, BY MATERIAL, 2021-2031 (REVENUE, $MILLION)

TABLE 87. LAMEA SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 88. LAMEA SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 89. LAMEA SOFTGEL CAPSULES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 90. BRAZIL SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 91. BRAZIL SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 92. BRAZIL SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 93. SAUDI ARABIA SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 94. SAUDI ARABIA SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 95. SAUDI ARABIA SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 96. SOUTH AFRICA SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 97. SOUTH AFRICA SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 98. SOUTH AFRICA SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 99. REST OF LAMEA SOFTGEL CAPSULES MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 100. REST OF LAMEA SOFTGEL CAPSULES MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 101. REST OF LAMEA SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)

TABLE 102.AENOVA GROUP: COMPANY SNAPSHOT

TABLE 103.AENOVA GROUP: OPERATING SEGMENTS

TABLE 104.AENOVA GROUP: PRODUCT PORTFOLIO

TABLE 105.AENOVA GROUP: NET SALES,

TABLE 106.AENOVA GROUP: KEY STRATERGIES

TABLE 107.BEST FORMULATIONS, INC.: COMPANY SNAPSHOT

TABLE 108.BEST FORMULATIONS, INC.: OPERATING SEGMENTS

TABLE 109.BEST FORMULATIONS, INC.: PRODUCT PORTFOLIO

TABLE 110.BEST FORMULATIONS, INC.: NET SALES,

TABLE 111.BEST FORMULATIONS, INC.: KEY STRATERGIES

TABLE 112.CAPTEK SOFTGEL INTERNATIONAL, INC.: COMPANY SNAPSHOT

TABLE 113.CAPTEK SOFTGEL INTERNATIONAL, INC.: OPERATING SEGMENTS

TABLE 114.CAPTEK SOFTGEL INTERNATIONAL, INC.: PRODUCT PORTFOLIO

TABLE 115.CAPTEK SOFTGEL INTERNATIONAL, INC.: NET SALES,

TABLE 116.CAPTEK SOFTGEL INTERNATIONAL, INC.: KEY STRATERGIES

TABLE 117.CATALANT, INC.: COMPANY SNAPSHOT

TABLE 118.CATALANT, INC.: OPERATING SEGMENTS

TABLE 119.CATALANT, INC.: PRODUCT PORTFOLIO

TABLE 120.CATALANT, INC.: NET SALES,

TABLE 121.CATALANT, INC.: KEY STRATERGIES

TABLE 122.DCC PLC. (EUROCAPS): COMPANY SNAPSHOT

TABLE 123.DCC PLC. (EUROCAPS): OPERATING SEGMENTS

TABLE 124.DCC PLC. (EUROCAPS): PRODUCT PORTFOLIO

TABLE 125.DCC PLC. (EUROCAPS): NET SALES,

TABLE 126.DCC PLC. (EUROCAPS): KEY STRATERGIES

TABLE 127.PROCAPS GROUPS: COMPANY SNAPSHOT

TABLE 128.PROCAPS GROUPS: OPERATING SEGMENTS

TABLE 129.PROCAPS GROUPS: PRODUCT PORTFOLIO

TABLE 130.PROCAPS GROUPS: NET SALES,

TABLE 131.PROCAPS GROUPS: KEY STRATERGIES

TABLE 132.ROBINSON PHARMA, INC.: COMPANY SNAPSHOT

TABLE 133.ROBINSON PHARMA, INC.: OPERATING SEGMENTS

TABLE 134.ROBINSON PHARMA, INC.: PRODUCT PORTFOLIO

TABLE 135.ROBINSON PHARMA, INC.: NET SALES,

TABLE 136.ROBINSON PHARMA, INC.: KEY STRATERGIES

TABLE 137.LYFE GROUP (CAPS CANADA): COMPANY SNAPSHOT

TABLE 138.LYFE GROUP (CAPS CANADA): OPERATING SEGMENTS

TABLE 139.LYFE GROUP (CAPS CANADA): PRODUCT PORTFOLIO

TABLE 140.LYFE GROUP (CAPS CANADA): NET SALES,

TABLE 141.LYFE GROUP (CAPS CANADA): KEY STRATERGIES

TABLE 142.SIRIO PHARMA CO. (AYANDA): COMPANY SNAPSHOT

TABLE 143.SIRIO PHARMA CO. (AYANDA): OPERATING SEGMENTS

TABLE 144.SIRIO PHARMA CO. (AYANDA): PRODUCT PORTFOLIO

TABLE 145.SIRIO PHARMA CO. (AYANDA): NET SALES,

TABLE 146.SIRIO PHARMA CO. (AYANDA): KEY STRATERGIES

TABLE 147.THERMOFISHER SCIENTIFIC, INC (PATHEON): COMPANY SNAPSHOT

TABLE 148.THERMOFISHER SCIENTIFIC, INC (PATHEON): OPERATING SEGMENTS

TABLE 149.THERMOFISHER SCIENTIFIC, INC (PATHEON): PRODUCT PORTFOLIO

TABLE 150.THERMOFISHER SCIENTIFIC, INC (PATHEON): NET SALES,

TABLE 151.THERMOFISHER SCIENTIFIC, INC (PATHEON): KEY STRATERGIES LIST OF FIGURES

FIGURE 1.SOFTGEL CAPSULES MARKET SEGMENTATION

FIGURE 2.SOFTGEL CAPSULES MARKET,2021-2031

FIGURE 3.SOFTGEL CAPSULES MARKET,2021-2031

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.SOFTGEL CAPSULES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.PATENT ANALYSIS BY COMPANY

FIGURE 13.PATENT ANALYSIS BY COUNTRY

FIGURE 14.SOFTGEL CAPSULES MARKET,BY TYPE,2021(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULES MARKET,2021-2031(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF NON-GELATIN SOFTGEL CAPSULES SOFTGEL CAPSULES MARKET,2021-2031(%)

FIGURE 17.SOFTGEL CAPSULES MARKET,BY APPLICATION,2021(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICALS SOFTGEL CAPSULES MARKET,2021-2031(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HEALTH SUPPLEMENTS SOFTGEL CAPSULES MARKET,2021-2031(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF COSMETICS SOFTGEL CAPSULES MARKET,2021-2031(%)

FIGURE 21.SOFTGEL CAPSULES MARKET,BY DISTRIBUTION CHANNEL,2021(%)

FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SUPERMARKETS AND HYPERMARKETS SOFTGEL CAPSULES MARKET,2021-2031(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF PHARMACIES AND DRUG STORES SOFTGEL CAPSULES MARKET,2021-2031(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ONLINE PROVIDERS SOFTGEL CAPSULES MARKET,2021-2031(%)

FIGURE 25.SOFTGEL CAPSULES MARKET BY REGION,2021

FIGURE 26.U.S. SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 27.CANADA SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 28.MEXICO SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 29.GERMANY SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 30.FRANCE SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 31.UK SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 32.ITALY SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 33.SPAIN SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 34.REST OF EUROPE SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 35.JAPAN SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 36.CHINA SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 37.INDIA SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 38.AUSTRALIA SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 39.SOUTH KOREA SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 40.REST OF ASIA-PACIFIC SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 41.BRAZIL SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 42.SAUDI ARABIA SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 43.SOUTH AFRICA SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 44.REST OF LAMEA SOFTGEL CAPSULES MARKET,2021-2031($MILLION)

FIGURE 45. TOP WINNING STRATEGIES, BY YEAR

FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 49.COMPETITIVE DASHBOARD

FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 51.AENOVA GROUP.: NET SALES ($MILLION)

FIGURE 52.BEST FORMULATIONS, INC..: NET SALES ($MILLION)

FIGURE 53.CAPTEK SOFTGEL INTERNATIONAL, INC..: NET SALES ($MILLION)

FIGURE 54.CATALANT, INC..: NET SALES ($MILLION)

FIGURE 55.DCC PLC. (EUROCAPS).: NET SALES ($MILLION)

FIGURE 56.PROCAPS GROUPS.: NET SALES ($MILLION)

FIGURE 57.ROBINSON PHARMA, INC..: NET SALES ($MILLION)

FIGURE 58.LYFE GROUP (CAPS CANADA).: NET SALES ($MILLION)

FIGURE 59.SIRIO PHARMA CO. (AYANDA).: NET SALES ($MILLION)

FIGURE 60.THERMOFISHER SCIENTIFIC, INC (PATHEON).: NET SALES ($MILLION